Table 2. Clinical characteristics of... | American Society of Hematology

Table 2.

Clinical characteristics of intestinal GVHD (I-GVHD) patients

	GVHD grading
Patient	Overall	I-GVHD	Biopsy-proven I-GVHD	GCV pk after V-GCV administration	Remark
Group A, val/gan
1	I	I	Yes	Adequate	Diarrhea > 500 mL/day
2	III	II	Yes	Adequate	Diarrhea > 1000 mL/day
3	II	III	Yes	Severe malabsorption	Severe I-GVHD (diarrhea > 1000 mL/day) for weeks, decreasing prior to randomization; GVHD of the liver (grade II)
Group B, gan/val
1	II	I	No^*	Adequate	Diarrhea (≤ 10 × in total 600 mL/day); severe GVHD of the skin (grade III)
2	II	II	Yes	Adequate	Outpatient care
3	III	II	Yes	Adequate	Outpatient care

	GVHD grading
Patient	Overall	I-GVHD	Biopsy-proven I-GVHD	GCV pk after V-GCV administration	Remark
Group A, val/gan
1	I	I	Yes	Adequate	Diarrhea > 500 mL/day
2	III	II	Yes	Adequate	Diarrhea > 1000 mL/day
3	II	III	Yes	Severe malabsorption	Severe I-GVHD (diarrhea > 1000 mL/day) for weeks, decreasing prior to randomization; GVHD of the liver (grade II)
Group B, gan/val
1	II	I	No^*	Adequate	Diarrhea (≤ 10 × in total 600 mL/day); severe GVHD of the skin (grade III)
2	II	II	Yes	Adequate	Outpatient care
3	III	II	Yes	Adequate	Outpatient care

val indicates valganciclovir; and gan, ganciclovir.

This patient had diarrhea between 500 and 1000 mL/day and a coexisting cutaneous aGVHD grade III, indicating the diarrhea to be due to intestinal GVHD

View Large

This Feature Is Available To Subscribers Only